EUVIMEDEUVIMED entdecken
Multizentrische StudieOpen Access · CC BY-NC 4.0

GDF-15 at Admission Predicts Cardiovascular Death, Heart Failure, and Bleeding Outcomes in Patients with CAD

Jiali Wang, Tao Zhang, Feng Xu, Wei Gao, Ming Chen, Huadong Zhu, Jun Xu, Xinxin Yin, Jiaojiao Pang, Song Zhang, Mengke Wei, Jiahao Chen und 4 weitere

ESC Heart Failure · 2023

DOI: 10.1002/ehf2.14484 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift ESC Heart Failure, 2023. Verfasst von Jiali Wang und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Emergency and Chest Pain Center, Qilu Hospital of Shandong University, Jinan, China. Hauptthemen laut MEDLINE: Growth Differentiation Factor 15, Heart Failure, Hemorrhage, Coronary Artery Disease. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: National Key Research and Development Program of China, National Science and Technology Fundamental Resources Investigation Project, Key Research and Development Program of Shandong Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

We aimed to investigate the independent associations between growth differentiation factor 15 (GDF-15) level at admission and cardiovascular (CV) death, thrombotic events, heart failure (HF), and bleeding outcomes in patients with coronary artery disease (CAD). Methods and results We measured the plasma concentrations of GDF-15 centrally in patients from the BIomarker-based Prognostic Assessment for patients with Stable angina and acute coronary Syndrome (BIPass) registry, which consecutively enrolled patients with CAD from November 2017 to September 2019 at five tertiary hospitals in China. The outcomes included CV death, thrombotic events [myocardial infarction (MI) and ischaemic stroke], HF events [acute HF during hospitalization and hospitalization for HF post-discharge (A/H HF) and cardiogenic shock], and bleeding outcomes [non-coronary artery bypass grafting-related major bleeding and clinically significant bleeding (CSB)] during the 12 month follow-up period after hospitalization. Among 6322 patients with CAD {65.4% male, median age 63.7 [inter-quartile range (IQR)] 56.0–70.1 years}, the median concentration of plasma GDF-15 at admission was 1091 (IQR 790.5–1635.0) ng/L. Higher concentrations of GDF-15 were associated with an increased risk of CV death [hazard ratio (HR) 1.98, 95% confidence interval (CI) 1.35–2.88, P < 0.001], A/H HF (HR 2.69, 95% CI 1.92–3.77, P < 0.001), cardiogenic shock (HR 1.46, 95% CI 1.04–2.05, P = 0.029), and CSB (HR 1.48, 95% CI 1.22–1.79, P < 0.001), but not for MI or stroke, after adjusting for clinical risk factors and prognostic biomarkers. Adding GDF-15 to the model with risk factors and biomarkers improved the net reclassification for CV death, A/H HF, cardiogenic shock, and CSB.

Conclusions

In patients with CAD, admission levels of GDF-15 were associated with an increased 1 year risk of CV death, HF, and bleeding outcomes, but not with thrombotic events. GDF-15 may be a prognostic biomarker for CV death, HF, and bleeding outcomes and could be used to refine the risk assessment of these specific clinical outcomes. Trial Registration: ClinicalTrials.gov Identifier: NCT04044066

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Growth Differentiation Factor 15Heart FailureHemorrhageCoronary Artery DiseaseRegistriesHumansMaleFemaleMiddle AgedAgedBiomarkersPrognosisFollow-Up StudiesChinaRisk FactorsSurvival RatePatient AdmissionRisk AssessmentCause of Death

Stichwörter der Autor:innen

BiomarkerClinical outcomesCoronary artery diseaseGrowth differentiation factor 15Prognostic value

Substanzen

Growth Differentiation Factor 15BiomarkersGDF15 protein, human

Autor:innen und Institutionen

  • Department of Emergency and Chest Pain Center, Qilu Hospital of Shandong University, Jinan, China.
  • Shandong Provincial Clinical Research Center for Emergency and Critical Care Medicine, Qilu Hospital of Shandong University, Jinan, China.
  • Key Laboratory of Emergency and Critical Care Medicine of Shandong Province, Qilu Hospital of Shandong University, Jinan, China.
  • Key Laboratory of Cardiovascular Remodeling and Function Research, Chinese Ministry of Education, Chinese National Health Commission and Chinese Academy of Medical Sciences, State and Shandong Province Joint Key Laborat…
  • Department of Biostatistics, School of Public Health, Cheeloo College of Medicine, Shandong University, Jinan, China.
  • Department of Cardiology, Peking University Third Hospital, Beijing, China.

Förderung

  • National Key Research and Development Program of China
  • National Science and Technology Fundamental Resources Investigation Project
  • Key Research and Development Program of Shandong Province
  • Taishan Pandeng Scholar Program of Shandong Province
  • Taishan Young Scholar Program of Shandong Province
  • Youth Top-Talent Project of National Ten Thousand Talents Plan and Qilu Young Scholar Program
  • ECCM Program of Clinical Research Center of Shandong University
  • Key Technology Research and Development Program of Shandong Province

Zitieren

APA

Wang, J., Zhang, T., Xu, F., Gao, W., Chen, M., Zhu, H., Xu, J., Yin, X., Pang, J., Zhang, S., Wei, M., Chen, J., Liu, Y., Yu, X., Chew, D. P., & Chen, Y. (2023). GDF-15 at Admission Predicts Cardiovascular Death, Heart Failure, and Bleeding Outcomes in Patients with CAD. ESC Heart Failure. https://doi.org/10.1002/ehf2.14484

Vancouver

Wang J, Zhang T, Xu F, Gao W, Chen M, Zhu H, et al. GDF-15 at Admission Predicts Cardiovascular Death, Heart Failure, and Bleeding Outcomes in Patients with CAD. ESC Heart Failure. 2023. doi:10.1002/ehf2.14484

BibTeX
@article{Wang2023,
  author = {Wang, Jiali and Zhang, Tao and Xu, Feng and Gao, Wei and Chen, Ming and Zhu, Huadong and Xu, Jun and Yin, Xinxin and Pang, Jiaojiao and Zhang, Song and Wei, Mengke and Chen, Jiahao and Liu, Ying and Yu, Xuezhong and Chew, Derek P and Chen, Yuguo},
  title = {GDF-15 at Admission Predicts Cardiovascular Death, Heart Failure, and Bleeding Outcomes in Patients with CAD},
  journal = {ESC Heart Failure},
  year = {2023},
  doi = {10.1002/ehf2.14484}
}
Kostenlos starten →